PLA0118
Rabbit anti-Phospho RPS6 (S235/236) Antibody, Affinity Purified
Powered by Bethyl Laboratories, Inc.
Szinonimák:
40S ribosomal protein S6, S6, phosphoprotein NP33
Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez
Összes fotó(1)
About This Item
UNSPSC kód:
12352203
NACRES:
NA.41
faj reaktivitás:
human
application:
WB
technika/technikák:
western blot: 1:2,500-1:10,000
citations:
8
Javasolt termékek
![Octahydrocyclopenta[c]pyrrole AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/385/398/e59a3455-5fde-4e4a-a173-43297760be22/640/e59a3455-5fde-4e4a-a173-43297760be22.png)
biológiai forrás
rabbit
Minőségi szint
antitest forma
affinity purified immunoglobulin
antitest terméktípus
primary antibodies
grade
Powered by Bethyl Laboratories, Inc.
faj reaktivitás
human
technika/technikák
western blot: 1:2,500-1:10,000
elérési szám
NP_001001.2
kiszállítva
wet ice
tárolási hőmérséklet
2-8°C
Géninformáció
human ... RPS6(6194)
Immunogén
Immunogen for PLA0118 was a phosphorylated synthetic peptide, which represented a portion of human Ribosomal Protein S6 (GeneID 6194) around serine 235 and serine 236 according to the numbering given in entry NP_001001.2.
Fizikai forma
Tris-buffered Saline containing 0.1% BSA containing 0.09% Sodium Azide
Egyéb megjegyzések
Ribosomal protein S6 (RPS6) is a component of the 40S ribosomal subunit. Ribosomes are composed of a small 40S subunit and a large 60S subunit that function to catalyze protein synthesis. RPS6 is phosphorylated by many cellular kinases including ribosomal protein S6 kinase that is regulated via the mammalian target of rapamycin (mTOR) pathway. RPS6 has been demonstrated to be important in regulating cell size, glucose homeostasis, and translational control of mRNA.
Jogi nyilatkozat
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Nem találja a megfelelő terméket?
Próbálja ki a Termékválasztó eszköz. eszközt
Tárolási osztály kódja
12 - Non Combustible Liquids
WGK
WGK 1
Lobbanási pont (F)
Not applicable
Lobbanási pont (C)
Not applicable
Válasszon a legfrissebb verziók közül:
Analitikai tanúsítványok (COA)
Lot/Batch Number
Nem találja a megfelelő verziót?
Ha egy adott verzióra van szüksége, a tétel- vagy cikkszám alapján rákereshet egy adott tanúsítványra.
Már rendelkezik ezzel a termékkel?
Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.
Zachary A Knight et al.
eLife, 3, e01913-e01913 (2014-09-10)
Red blood cells (RBC) must coordinate their rate of growth and proliferation with the availability of nutrients, such as iron, but the signaling mechanisms that link the nutritional state to RBC growth are incompletely understood. We performed a screen for
Wei Kang et al.
Journal of translational medicine, 12, 281-281 (2014-10-08)
Aberrant AKT activation contributes to gastric cancer cell survival and chemotherapy resistance, however its regulation is poorly understood. microRNAs have been established to be important regulators in gastric carcinogenesis. Here, we showed the functional role and putative target of let-7b
H Hamidi et al.
British journal of cancer, 111(9), 1788-1801 (2014-08-29)
To study the molecular mechanism regulating sensitivity to MEK inhibition in pancreatic cancer cell lines. A growth inhibition assay determined sensitivity to MEK162 in a panel of 29 pancreatic cancer cell lines. For the same panel, KRAS mutational status and
Djalila Mekahli et al.
Pflugers Archiv : European journal of physiology, 466(8), 1591-1604 (2013-11-07)
Autosomal dominant polycystic kidney disease (ADPKD) is caused by loss-of-function mutations in either PKD1 or PKD2 genes, which encode polycystin-1 (TRPP1) and polycystin-2 (TRPP2), respectively. Increased activity of the mammalian target of rapamycin (mTOR) pathway has been shown in PKD1
Selma Pennacchietti et al.
Cancer research, 74(22), 6598-6609 (2014-09-14)
Cell-based drug screenings indicate that tumors displaying c-MET gene amplification are "addicted" to MET signaling and therefore are very sensitive to MET-targeted agents. However, these screenings were conducted in the absence of the MET ligand, hepatocyte growth factor (HGF), which
Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.
Lépjen kapcsolatba a szaktanácsadással